Vancouver, British Columbia and Rehovot, Israel–(Newsfile Corp. – August 18, 2022) – BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) (“BioHarvest” or “the Company”) has...
Purchase order of 1,000 kg for prompt delivery to support the growing demand for VINIA® Pipeline of 6 major customers testing VINIA® for inclusion in their...
VINIA® sales orders reached a record high of USD 947k representing 99% growth compared to Q2 2021 and 24% growth compared to Q1 2022 BioHarvest reiterates...
Gavriel Lambert’s 27 years of investment banking experience, covering the consumer and retail sectors and working on numerous capital markets transactions including IPOs, financings and M&A,...
Vancouver, British Columbia and Rehovot, Israel–(Newsfile Corp. – June 24, 2022) – BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or “the Company”) invites its shareholders and the general...
Move confirms the Company’s commitment to bring to market scientific and clinically based therapeutic solutions derived from plants and sets the path for the development of...
Full spectrum profile to include major and minor Cannabinoids as well as Terpenes Unique trichome structure provides for potentially higher solubility and bio-availability With Trichomes representing...
Vancouver, British Columbia and Rehovot, Israel–(Newsfile Corp. – April 7, 2022) – BioHarvest Sciences Inc. (CSE: BHSC) (OTC:CNVCF) (FSE: 8MV) ("BioHarvest" or the "Company") announced today a financing...
VINIA® sales orders grew 112% compared to Q1 2021 to reach USD 787k Reiterating guidance for year-on-year sales orders growth of 2.5-3.5X to reach USD 5M...
Now producing Cannabis biomass in large scale industrial bioreactors under the current R&D license. Commencing the process of transitioning the current Israeli Cannabis R&D license to...